Practice
Open Access
Possible association between rhabdomyolysis and mRNA SARS-CoV-2 vaccination in a patient with RYR1 gene mutation
Brittany Salter, Matthew Jessome, Mark Tarnopolsky and Haroon Yousuf
CMAJ February 22, 2022 194 (7) E252-E256; DOI: https://doi.org/10.1503/cmaj.211856
Brittany Salter
Departments of Medicine (Salter, Yousuf), Rheumatology (Jessome) and Neurology (Tarnopolsky), McMaster University, Hamilton, Ont.
Matthew Jessome
Departments of Medicine (Salter, Yousuf), Rheumatology (Jessome) and Neurology (Tarnopolsky), McMaster University, Hamilton, Ont.
Mark Tarnopolsky
Departments of Medicine (Salter, Yousuf), Rheumatology (Jessome) and Neurology (Tarnopolsky), McMaster University, Hamilton, Ont.
Haroon Yousuf
Departments of Medicine (Salter, Yousuf), Rheumatology (Jessome) and Neurology (Tarnopolsky), McMaster University, Hamilton, Ont.

Data supplements
Earn CPD Credits
This article is eligible for 0.5 Mainpro+ credits.
Did you read this article?
Related Articles
- Salter, B., Jessome, M., Tarnopolsky, M., & Yousuf, H. (2022). Lien possible entre rhabdomyolyse et vaccin anti-SRAS-CoV-2 à ARNm chez une patiente porteuse d’une mutation du gène RYR1. CMAJ, 194(12), E473-E478. Accessed May 29, 2023. https://doi.org/10.1503/cmaj.211856-f.
- Blais, A. (2022). Succinylcholine, malignant hyperthermia and rhabdomyolysis. CMAJ, 194(25), E878. Accessed May 29, 2023. https://doi.org/10.1503/cmaj.146480-l.
In this issue
Article tools
Respond to this article
Possible association between rhabdomyolysis and mRNA SARS-CoV-2 vaccination in a patient with RYR1 gene mutation
Brittany Salter, Matthew Jessome, Mark Tarnopolsky, Haroon Yousuf
CMAJ Feb 2022, 194 (7) E252-E256; DOI: 10.1503/cmaj.211856
Jump to section
Related Articles
Cited By...
- No citing articles found.